Pharmacogenomic Testing
The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.
Year introduced: 2017
PubMed search builder options
Subheadings:
Tree Number(s): E01.370.225.562.500, E05.200.562.500, E05.393.435.500, N02.421.308.430.500, N02.421.726.233.221.500
MeSH Unique ID: D000071185
Entry Terms:
- Pharmacogenomic Testings
- Pharmacogenetic Testing
- Pharmacogenetic Testings
- Pharmacogenomic Screening
- Pharmacogenomic Screenings
- Pharmacogenetic Screening
- Pharmacogenetic Screenings
- Pharmacogenomic Analysis
- Pharmacogenomic Analyses
- Pharmacogenomic Study
- Pharmacogenomic Studies
- Pharmacogenetic Analysis
- Pharmacogenetic Analyses
- Pharmacogenetic Study
- Pharmacogenetic Studies
- Studies, Pharmacogenetic
Previous Indexing: